Regional News

Beat the Heat: Pigenius' New Sunshade Guide Helps Drivers Stay Cool This Summer

LOS ANGELES, July 3, 2025 /PRNewswire/ -- When it comes to protecting car owners and cars from the scorching sun, a high-quality sunshade is the essential accessory. For 30 years, Pigenius has focused solely on car sunshades, committed to protecting vehicle interiors and enhancing driving comfor...

2025-07-03 20:03 2243

NUS researchers develop novel material for water quality monitoring device

Introducing ReSURF sensor – an ultrafast, stretchable, self-healing and recyclable sensing device that enables on-site, real-time surveillance of water quality within milliseconds SINGAPORE, July 3, 2025 /PRNewswire/ -- Clean, safe water is vital for human health and well-being. It also plays a ...

2025-07-03 19:41 4780

Fangzhou Tops China's App Store Chart for Healthcare Apps

GUANGZHOU, China, July 3, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in theJune 2025 China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy App, according to a report by ...

2025-07-03 18:43 2239

Beyond Boundaries: Envision's Record 49-Hour Fire Test Breaks New Ground in Energy Storage Safety

SHANGHAI, July 3, 2025 /PRNewswire/ -- Envision Energy, a global leader in green technology, has successfully completed a groundbreaking large-scale fire test for its smart energy storage system, raising the bar for safety, environmental responsibility, and system resilience. Conducted under full...

2025-07-03 18:33 2069

Yunji Announces Changes in Management

HANGZHOU, China, July 3, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that Mr.Yeqing Cui, has resigned as Senior Financial Director and finance in charge of the Company for personal reasons, effecti...

2025-07-03 18:30 2151

MOTE Therapeutics Taps MaryJane Rafii as Chief Investment & Business Officer to Drive Global Growth of RNA Delivery Platform

BOSTON, July 3, 2025 /PRNewswire/ -- MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment ofMaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer. The move comes as MOTE accelerates development of its MOBILIZ...

2025-07-03 18:07 2198

So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 3, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that it has received a written compliance notification f...

2025-07-03 17:00 4154

Modlily Launches "Summer of Self-Love" BOGO Campaign, Celebrating Confidence Through Fashion

LOS ANGELES, July 2, 2025 /PRNewswire/ -- International women's fashion brand Modlily—known for affordable, body-positive apparel—today launched its seasonal "Summer of Self-Love" Buy One, Get One (BOGO) Free promotion. From  July 1 through July 20, customers can refresh their summer wardrobes wit...

2025-07-03 15:54 2100

Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 Strategy

HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's first bispec...

2025-07-03 14:46 2380

Andrés Iniesta, ambassador of fair play with MelBet

MADRID, July 3, 2025 /PRNewswire/ -- International company MelBet has announced a partnership with one of the best midfielders in football history – Barcelona legend, World Cup winner and two-time European champion Andrés Iniesta. The foundation for a productive partnership is the parties' desire...

2025-07-03 14:00 2607

Wei Zhou Named Among Caijing Magazine's Top 50 Global Chinese Venture Capitalists

PALO ALTO, Calif., July 3, 2025 /PRNewswire/ -- Recently, the prestigious media platform Caijing Magazine officially unveiled its "Top 50 Global Chinese Venture Capitalists" list.Wei Zhou, Founding Managing Partner of Cyber Creation Ventures (CCV), earned a coveted spot on the list thanks to his ...

2025-07-03 12:07 2761

MiniTool Released Video Converter 4.3 with New Features

VANCOUVER, BC, July 2, 2025 /PRNewswire/ -- MiniTool Software Limited has released a new version of its video conversion tool – MiniTool Video Converter 4.3. This update brings a new video compression feature and optimizes the interface. Upgrade Highlights in MiniTool Video Converter 4.3 * ...

2025-07-03 09:53 1999

Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

* ZEGFROVY is the only approved targeted oral treatment for NSCLC with EGFR  exon20ins * Approval follows the U.S. FDA's Priority Review and is supported by the pivotal WU-KONG1 Part B study, in which ZEGFROVY demonstrated statistically significant and clinically meaningfulbenefits to patien...

2025-07-03 08:08 2272

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Highlights: * Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement * Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing da...

2025-07-03 07:09 2279

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

-  First participants with obesity or overweight with at least one weight-r elatedcomorbidity have been dosed in a U.S. 13-week Phase IIa study of small m oleculeoral GLP-1 receptor agonist ASC30. -  ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean  body weight reduction f...

2025-07-03 07:00 2187

TROOPS, Inc. (Nasdaq: TROO) Announces Update on Hong Kong High Court Judgment and Explores Strategic Legal Options to Safeguard Shareholder Interests

HONG KONG, July 2, 2025 /PRNewswire/ -- TROOPS, Inc. (Nasdaq: TROO) (the "Company" or "TROOPS") today announced that the Company has received a judgement (the "Judgement") issued by the High Court of Hong Kong Special Administrative Region Court of First Instance in connection with the action no....

2025-07-03 04:30 4604

FiEE, Inc. Acquires Advanced Tech Suite Expected to Supercharge IoT-AI Content & Audience Targeting Platform

HONG KONG, July 2, 2025 /PRNewswire/ -- FiEE, Inc. (NASDAQ:MINM) ("FiEE" or the "Company"), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, is pleased to announce that onJune 30, 2025, it entered into an asset purchase agreement...

2025-07-03 04:30 4501

Upgrade Your Water Experience: Waterdrop's Biggest Prime Day Deals Now Live

Save more on award-winning filtration systems from July 2-13 LOS ANGELES, July 2, 2025 /PRNewswire/ -- Waterdrop Filter , a leading innovator in water purification, is l...

2025-07-03 01:00 2321

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately assess and predict therapeutic outcomes in lymphoma patients across different subtypes—potentially transforming how clinic...

2025-07-02 23:00 2093

Boqii Holding Limited Announces Update on Substitution Listing and 1-for-160 Reverse Split

SHANGHAI, July 2, 2025 /PRNewswire/ -- As Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) previously announced, the Company plans to cease the listing of the American Depositary Shares (the "ADSs") representing its Class A ordinary shares of par valueUS$0.001 each on the  NYS...

2025-07-02 22:48 5055